Related references
Note: Only part of the references are listed.Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine
Maria Tsirogianni et al.
LEUKEMIA & LYMPHOMA (2019)
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Anna M. Paczulla et al.
NATURE (2019)
Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
Aimee Merino et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The HLA-B-21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia
Alexander Hallner et al.
BLOOD (2019)
Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells
Patrick L. Collins et al.
CELL (2019)
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
Yuanbin Song et al.
NATURE COMMUNICATIONS (2019)
NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia
Ming-Chin Chang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Adaptive NK cell reconstitution is associated with better clinical outcomes
Frank Cichocki et al.
JCI INSIGHT (2019)
Long-lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib
Tatsuro Jo et al.
ONCOLOGY LETTERS (2018)
Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring
Elias Jabbour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia
Todd A. Fehniger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Bjorklund et al.
CLINICAL CANCER RESEARCH (2018)
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors
Rajeswaran Mani et al.
HAEMATOLOGICA (2018)
Emergence of NK Cell Hyporesponsiveness after Two IL-15 Stimulation Cycles
Marie Frutoso et al.
JOURNAL OF IMMUNOLOGY (2018)
IL-2 and Beyond in Cancer Immunotherapy
John M. Wrangle et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Christopher Maximilian Arends et al.
LEUKEMIA (2018)
Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study
Yuho Najima et al.
LEUKEMIA RESEARCH (2018)
Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes
Wei Zhang et al.
ONCOLOGY LETTERS (2018)
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors
Rajeswaran Mani et al.
HAEMATOLOGICA (2018)
Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML
Hiroshi Ureshino et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Molecular Basis for the Recognition of Herpes Simplex virus Type 1 infection by Human natural Killer Cells
Hong-Sheng Dai et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities
Aude Le Roy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function
Steven D. Scoville et al.
BLOOD (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Human innate Lymphoid Cells: Their Functional and Cellular interactions in Decidua
Paola Vacca et al.
FRONTIERS IN IMMUNOLOGY (2018)
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier et al.
IMMUNITY (2018)
Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues
Roberta Castriconi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy
Sara Mastaglio et al.
BLOOD ADVANCES (2018)
Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice
Jeannette Cany et al.
BLOOD (2018)
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies
Cariad Chester et al.
BLOOD (2018)
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
Dhifaf Sarha et al.
BLOOD ADVANCES (2018)
An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
S. P. Koerner et al.
LEUKEMIA (2017)
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
M. Ilander et al.
LEUKEMIA (2017)
High-dose interleukin-2 (IL-2) for the treatment of melanoma: safety considerations and future directions
Stephen Marabondo et al.
EXPERT OPINION ON DRUG SAFETY (2017)
The clinicopathologic significance of lymphocyte subsets in acute myeloid leukemia
M. Alcasid et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2017)
KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation
Jeanette E. Boudreau et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
NOX2-dependent immunosuppression in chronic myelomonocytic leukemia
Johan Aurelius et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia
E. Bernson et al.
LEUKEMIA (2017)
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
Liran I. Shlush et al.
NATURE (2017)
Natural killer cell-mediated immunosurveillance of human cancer
Karl-Johan Malmberg et al.
SEMINARS IN IMMUNOLOGY (2017)
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien et al.
ONCOTARGET (2017)
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
Aroa Baragano Raneros et al.
ONCOTARGET (2017)
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2017)
In Vitro culture with interleukin-15 leads to expression of activating receptors and recovery of natural Killer cell Function in acute Myeloid Leukemia Patients
Beatriz Sanchez-Correa et al.
FRONTIERS IN IMMUNOLOGY (2017)
Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission
Amy Hughes et al.
FRONTIERS IN IMMUNOLOGY (2017)
Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells
Jerome Rey et al.
FRONTIERS IN IMMUNOLOGY (2017)
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
Anne-Sophie Chretien et al.
ONCOIMMUNOLOGY (2017)
The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
Isabel Goncalves Silva et al.
EBIOMEDICINE (2017)
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Frida Ewald Sander et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms
Bianca Tesi et al.
BLOOD (2017)
The chronic myeloid leukemia stem cell: stemming the tide of persistence
Tessa L. Holyoake et al.
BLOOD (2017)
CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors
Amy Hughes et al.
BLOOD (2017)
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
Loredana Ruggeri et al.
HAEMATOLOGICA (2016)
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
Loredana Ruggeri et al.
HAEMATOLOGICA (2016)
Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia
Anna Martner et al.
ONCOIMMUNOLOGY (2016)
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
Dean A. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts
Sumithira Vasu et al.
BLOOD (2016)
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
Helena Agerstam et al.
BLOOD (2016)
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
Antonio Curti et al.
CLINICAL CANCER RESEARCH (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma
Mattias Carlsten et al.
CLINICAL CANCER RESEARCH (2016)
Natural Killer Cell (NK) Subsets and NK-Like T-Cell Populations in Acute Myeloid Leukemias and Myelodysplastic Syndromes
N. Aggarwal et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia
Mohamed El Missiry et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
MicroRNA-29b mediates altered innate immune development in acute leukemia
Bethany L. Mundy-Bosse et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
NK cells and type 1 innate lymphoid cells: partners in host defense
Hergen Spits et al.
NATURE IMMUNOLOGY (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Repression of GSK3 restores NK cell cytotoxicity in AML patients
Reshmi Parameswaran et al.
NATURE COMMUNICATIONS (2016)
Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation
Angelica Cuapio et al.
ONCOTARGET (2016)
Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
Pallavi Sontakke et al.
STEM CELLS INTERNATIONAL (2016)
Recognition and Regulation of T Cells by NK Cells
Katharina Pallmer et al.
FRONTIERS IN IMMUNOLOGY (2016)
Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing
Conor J. Kearney et al.
ONCOIMMUNOLOGY (2016)
Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
Erwin M. Lee et al.
HAEMATOLOGICA (2015)
Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion
Zena Khaznadar et al.
JOURNAL OF IMMUNOLOGY (2015)
The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro
Jochen Vasold et al.
LEUKEMIA RESEARCH (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Richard W. Childs et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
Helena Agerstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance
Anna Martner et al.
ONCOTARGET (2015)
Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
Erwin M. Lee et al.
HAEMATOLOGICA (2015)
NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML
Patrick Schlegel et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Increased NK cell maturation in patients with acute myeloid leukemia
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2015)
Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer
Jeannette Cany et al.
ONCOIMMUNOLOGY (2015)
Expanding role of lenalidomide in hematologic malignancies
Nilanjan Ghosh et al.
CANCER MANAGEMENT AND RESEARCH (2015)
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial
Panagiotis D. Kottaridis et al.
PLOS ONE (2015)
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells
Eva Nievergall et al.
BLOOD (2014)
The evolution of cellular deficiency in GATA2 mutation
Rachel E. Dickinson et al.
BLOOD (2014)
Can Treg elimination enhance NK cell therapy for AML?
Cliona M. Rooney
BLOOD (2014)
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
Masaru Imamura et al.
BLOOD (2014)
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Michelle K. Gleason et al.
BLOOD (2014)
Immune evasion by oncogenic proteins of acute myeloid leukemia
Shlomo Elias et al.
BLOOD (2014)
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Veronika Bachanova et al.
BLOOD (2014)
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo
Petter S. Woll et al.
CANCER CELL (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse
Zena Khaznadar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
Kate Stringaris et al.
HAEMATOLOGICA (2014)
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC
S. J. Busfield et al.
LEUKEMIA (2014)
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Liran I. Shlush et al.
NATURE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP
Maria Askmyr et al.
BLOOD (2013)
Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Andres Wiernik et al.
CLINICAL CANCER RESEARCH (2013)
Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study
Takayoshi Uchiyama et al.
HEMATOLOGICAL ONCOLOGY (2013)
Natural killer cell deficiency
Jordan S. Orange
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Receptor Activator for NF-κB Ligand in Acute Myeloid Leukemia: Expression, Function, and Modulation of NK Cell Immunosurveillance
Benjamin Joachim Schmiedel et al.
JOURNAL OF IMMUNOLOGY (2013)
Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes
Johan Aurelius et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice
Jeannette Cany et al.
PLOS ONE (2013)
Location and cellular stages of natural killer cell development
Jianhua Yu et al.
TRENDS IN IMMUNOLOGY (2013)
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Obinna Chijioke et al.
CELL REPORTS (2013)
Shaping of NK Cell Responses by the Tumor Microenvironment
Ana Stojanovic et al.
CANCER MICROENVIRONMENT (2013)
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
Bree Foley et al.
BLOOD (2012)
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
Laura Barreyro et al.
BLOOD (2012)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey et al.
BLOOD (2012)
Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency
Rachel K. Shaw et al.
BLOOD (2012)
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Saar Gill et al.
BLOOD (2012)
Antibody-Dependent Cell-Mediated Cytotoxicity Overcomes NK Cell Resistance in MLL-Rearranged Leukemia Expressing Inhibitory KIR Ligands but Not Activating Ligands
Wing Keung Chan et al.
CLINICAL CANCER RESEARCH (2012)
Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients
Beatriz Sanchez-Correa et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
Julia Hilpert et al.
JOURNAL OF IMMUNOLOGY (2012)
Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
Bree Foley et al.
JOURNAL OF IMMUNOLOGY (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models
Eva Rettinger et al.
FRONTIERS IN ONCOLOGY (2012)
Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission
Nicolas Dauguet et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands
Beatriz Sanchez-Correa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report
Stacey L. Berg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses
Maria Salagianni et al.
JOURNAL OF IMMUNOLOGY (2011)
TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells
Mitsuhiro Iyori et al.
JOURNAL OF IMMUNOLOGY (2011)
CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
S. J. Coles et al.
LEUKEMIA (2011)
Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor-Negative Natural Killer Cells after NKG2A and LIR-1 Blockade
Robert Godal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
Tina Baessler et al.
BLOOD (2010)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
Miroslaw J. Szczepanski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
Uwe Siegler et al.
CYTOTHERAPY (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
M. Carlsten et al.
LEUKEMIA (2010)
AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
M. Wunderlich et al.
LEUKEMIA (2010)
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
Marcus Jaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
Yenan T. Bryceson et al.
BLOOD (2009)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagne et al.
BLOOD (2009)
HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT
S. Nguyen et al.
BONE MARROW TRANSPLANTATION (2009)
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells
Sonja Verheyden et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
Liqing Jin et al.
CELL STEM CELL (2009)
Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
Mattias Carlsten et al.
JOURNAL OF IMMUNOLOGY (2009)
Post-consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML
A. I. Romero et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Jerome D. Coudert et al.
BLOOD (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720
Maria R. Baer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Accelerated tumor growth in mice deficient in DNAM-1 receptor
Akiko Iguchi-Manaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Human tumor-derived exosomes down-modulate NKG2D expression
Aled Clayton et al.
JOURNAL OF IMMUNOLOGY (2008)
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities
Stefan Diermayr et al.
BLOOD (2008)
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
Pearlie K. Epling-Burnette et al.
BLOOD (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Human NK cell education by inhibitory receptors for MHC class I
Nicolas Anfossi et al.
IMMUNITY (2006)
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
Mats Brune et al.
BLOOD (2006)
Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice
F Guimaraes et al.
LEUKEMIA (2006)
BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia
Nicolas Boissel et al.
JOURNAL OF IMMUNOLOGY (2006)
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes
JJ Kiladjian et al.
LEUKEMIA (2006)
The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation
C Cebo et al.
JOURNAL OF IMMUNOLOGY (2006)
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression
Hyunkeun Song et al.
CELLULAR IMMUNOLOGY (2006)
Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice
U Siegler et al.
LEUKEMIA (2005)
Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells
YT Bryceson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
BCR/ABL promotes dendritic cell-mediated natural killer cell activation
M Terme et al.
CANCER RESEARCH (2005)
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
KC Hsu et al.
BLOOD (2005)
Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias
P Nowbakht et al.
BLOOD (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
D Pende et al.
BLOOD (2005)
Rituximab-dependent cytotoxicity by natural killer cells:: Influence of FCGR3A polymorphism on the concentration-effect relationship
S Dall'Ozzo et al.
CANCER RESEARCH (2004)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Interplay of natural killer cells and their receptors with the adaptive immune response
DH Raulet
NATURE IMMUNOLOGY (2004)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs)
EG Chiorean et al.
BLOOD (2003)
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells
MW Lowdell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
RT Costello et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission
GF Torelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients
H Nakajima et al.
JOURNAL OF IMMUNOLOGY (2002)
Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function - implications for the adoptive immunotherapy of leukaemia
JK Orleans-Lindsay et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells
V Screpanti et al.
JOURNAL OF IMMUNOLOGY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia
EK Cho et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting
I Miura et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Detection of the BCR-ABL fusion gene in natural killer cells in patients with chronic myelogenous leukemia
CK Min et al.
ACTA HAEMATOLOGICA (2000)
Share Paper
